Crossmark

Reperfusion and cytoprotective agents are a mutually beneficial pair in ischaemic stroke therapy: an overview of pathophysiology, pharmacological targets and candidate drugs focusing on excitotoxicity and free radical

Crossref DOI link: https://doi.org/10.1136/svn-2023-002671

Published Online: 2023-10-13

Published Print: 2024-08

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Xu, Xiumei

Chen, Mingyu

Zhu, Dongya https://orcid.org/0000-0002-2145-0225
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82090042)

National Key Research and Development Program of China (2021YFA1101803)
License Information

License valid from 2023-10-13

Document is current

Any future updates will be listed below